Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals

Why did India and Pakistan agree to a ceasefire? How will US-China trade talks impact tariffs? Why is Panasonic cutting 10,000 jobs globally? What caused Expedia's revenue miss this quarter? How are Trump's tariffs affecting US small businesses? Why did Google agree to pay $1.4 billion settlement? What is driving Tesla's recent stock surge? How is Biden administration's trade policy evolving? Why was Newark mayor arrested at ICE facility?

Tempus AI Rallies After Q1 Beat, Analyst Notes AI-Driven Platform And Expanding Pharma Deals

benzinga.com/general/health-care/25/05/45267309/tempus-ai-rallies-after-q1-beat-analyst-notes-ai-driven-platform-and-expanding-pharma-deals

JP Morgan analyst Rachel Vatnsdal reiterated the Neutral rating on Tempus AI, Inc. (NASDAQ:TEM) on Wednesday, with a price forecast of $55.
On Tuesday, Tempus AI reported first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The AI-focused precision medicine and…

This story appeared on benzinga.com, 2025-05-07 20:24:37.